stockrow
Friday 6 November 2026
Export XGN’s income statement to Excel — free account
Exagen Inc.
XGN Healthcare Diagnostics & Research
Exagen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $66.6 million, up 19.7% from fiscal 2024.
- Revenue
- +15.9%
- EPS
- +38.1%
- Free cash flow
- +211.3%
- Total debt
- +6.44%
Quarter to June 2026, against a year earlier
5.80
1.80
−23.68%
Follow XGN
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 5 | 1 | 3 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.97 | 1.34 | 0.66 | 0.92 | 3.85 | 3.97 | 2.25 | 0.00 | 0.00 |
Altman Z-Score |
(4.58) | (7.09) | (5.89) | (3.94) | 1.29 | 0.34 | 0.19 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(14.91) | (19.87) | (13.84) | (7.44) | 1.00 | (2.47) | 0.60 | (15.74) | — |
P/Operating CF |
(43.50) | 205.60 | 4.17 | (7.33) | (30.72) | (42.77) | (23.15) | (0.54) | (0.54) |
Beneish M-Score |
(2.80) | (2.62) | (3.19) | (3.69) | (2.61) | (2.19) | (2.69) | — | — |
P/B ratio |
7.51 | 7.82 | 1.53 | 0.99 | 2.19 | 3.99 | 1.63 | 0.00 | 0.00 |
Price to Tangible BV |
10.98 | 18.50 | 2.03 | 1.14 | 2.34 | 4.59 | 1.81 | 0.00 | 0.00 |
EV/Sales |
1.86 | 1.31 | 0.34 | 0.19 | 2.37 | 3.25 | 1.11 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(9.08) | (5.50) | (1.23) | (0.27) | (5.64) | (9.68) | (4.63) | (0.94) | (0.94) |
EV/FCF |
(8.68) | (5.29) | (1.17) | (0.24) | (5.05) | (9.37) | (4.58) | (0.92) | (0.92) |
Quick Ratio |
3.04 | 2.21 | 3.62 | 7.12 | 11.71 | 7.57 | 13.20 | 2.14 | 2.37 |
Current Ratio |
3.45 | 2.70 | 4.02 | 7.55 | 12.10 | 8.04 | 13.78 | 2.38 | 2.66 |
Net Debt/EBITDA |
0.68 | 0.14 | 0.83 | 0.86 | 3.13 | 2.12 | 5.74 | (4.29) | (1.18) |
Debt/Assets |
42.86% | 45.65% | 34.24% | 33.60% | 22.73% | 34.41% | 29.55% | 98.48% | 0.00% |
Debt/Equity |
1.43 | 2.14 | 0.86 | 0.68 | 0.33 | 0.64 | 0.47 | (4.22) | (4.25) |
Asset Turnover |
1.30 | 1.09 | 0.73 | 0.43 | 0.48 | 0.50 | 0.69 | 1.49 | 3.67 |
Operating CF/Net income |
0.68 | 0.88 | 0.61 | 0.68 | 0.75 | 0.84 | 0.32 | 0.50 | 0.33 |
Capex/Depreciation |
(0.19) | (0.27) | (0.35) | (0.60) | (1.93) | (0.55) | (0.08) | (0.15) | 0.00 |
Interest Coverage |
(3.26) | (6.10) | (9.78) | (18.81) | (9.17) | (5.92) | (2.66) | (1.70) | (5.35) |
| (147.85%) | (93.78%) | (72.72%) | (74.39%) | (42.36%) | (34.23%) | 107.55% | 17.72% | 41.96% | |
| (38.85%) | (29.74%) | (33.09%) | (45.20%) | (26.61%) | (20.02%) | (51.67%) | (84.95%) | (448.13%) | |
ROIC |
(87.10%) | (107.80%) | (250.58%) | (318.49%) | (110.94%) | (83.56%) | (60.12%) | (35.67%) | 0.00% |
Return on Tangible Assets |
(47.88%) | (53.54%) | (57.58%) | (66.57%) | (24.82%) | (26.14%) | (39.46%) | (132.72%) | (340.93%) |
Average Days of Receivables |
59.51 | 51.40 | 45.50 | 48.68 | 72.96 | 77.48 | 51.65 | 66.97 | 8.22 |
Research and Development Expense of Revenue |
0.00% | 9.66% | 9.26% | 21.68% | 14.98% | 8.50% | 5.39% | 6.55% | 5.79% |
Selling, General and Administrative Expense of Revenue |
70.02% | 74.36% | 90.26% | 114.17% | 92.22% | 88.23% | 71.07% | 60.65% | 70.21% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.07 | 0.06 | 0.19 | 0.00 |
Share Based Compensation of Revenue |
3.24% | 3.17% | 6.88% | 10.32% | 9.79% | 6.42% | 1.42% | 0.35% | 0.00% |
Graham Net Nets |
0.06 | 0.02 | 0.39 | 0.69 | 0.40 | 0.20 | 0.53 | 18.21 | 18.21 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(15.13%) | (20.24%) | (68.02%) | (108.94%) | (14.62%) | (10.00%) | (388.53%) | (35.48%) | (35.48%) |
Free Cash Flow Yield |
(10.87%) | (18.48%) | (43.83%) | (86.77%) | (12.19%) | (8.72%) | (10.80%) | (1,169.80%) | (1,169.80%) |
Revenue per Share |
3.09 | 3.06 | 2.97 | 2.67 | 3.02 | 3.32 | 11.28 | 514.92 | 2.23 |
Operating CF per Share |
(0.63) | (0.73) | (0.82) | (1.88) | (1.27) | (1.11) | (2.71) | (147.63) | (0.91) |
Capex per Share |
(0.03) | (0.03) | (0.05) | (0.25) | (0.15) | (0.04) | (0.03) | (3.16) | 0.00 |
Free Cash Flow per Share |
(0.66) | (0.76) | (0.86) | (2.13) | (1.42) | (1.15) | (2.74) | (150.79) | (0.91) |
Cash per Share |
1.49 | 1.21 | 2.06 | 3.65 | 6.23 | 4.55 | 20.14 | 208.95 | 0.93 |
Shareholders Equity per Share |
0.81 | 0.52 | 1.28 | 2.49 | 5.32 | 3.31 | 15.55 | (106.89) | (0.39) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.81 | 0.52 | 1.28 | 2.49 | 5.32 | 3.31 | 15.55 | (106.89) | (0.39) |
Free Cash Flow |
(14.25) | (13.79) | (15.27) | (36.46) | (22.64) | (14.54) | (9.81) | (9.50) | (10.97) |
Working Capital |
34.73 | 22.95 | 35.94 | 62.99 | 103.42 | 61.75 | 75.36 | 12.36 | 8.27 |
Capital Expenditures |
(0.63) | (0.51) | (0.80) | (4.32) | (2.37) | (0.45) | (0.10) | (0.20) | (0.57) |
Net Current Asset Value |
8.32 | 1.31 | 13.59 | 28.85 | 74.23 | 33.98 | 48.60 | (14.31) | (12.16) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.09 | 0.05 | 0.01 | 0.00 | 0.01 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.47 | 0.36 | 0.45 | 0.88 | 0.26 | 0.39 | 0.93 | 0.84 | 0.50 |
Cash ROIC |
(19.12%) | (26.54%) | (19.40%) | (27.25%) | (10.66%) | (11.52%) | (6.38%) | (27.24%) | (41.65%) |
Accounts Receivable Turnover |
7.12 | 7.74 | 8.32 | 5.79 | 5.20 | 5.74 | 6.92 | 9.90 | 8.18 |
Accounts Payable Turnover |
6.70 | 6.20 | 7.48 | 8.74 | 7.48 | 7.38 | 13.65 | 10.08 | 7.24 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 16.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
54.57 | 67.02 | 49.49 | 45.92 | 44.18 | 66.44 | 28.64 | 30.36 | 45.16 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
9.35 | 7.19 | 6.31 | 7.87 | 9.28 | 7.31 | 5.83 | 3.28 | 3.28 |
Average Payables |
4.15 | 3.63 | 3.09 | 2.77 | 2.75 | 2.25 | 1.38 | 1.53 | 1.98 |
Average Inventory |
— | — | — | 1.44 | — | — | — | — | — |
Average Assets |
51.36 | 50.82 | 71.58 | 104.83 | 100.91 | 83.34 | 58.60 | 21.76 | 7.31 |
Average Common Equity |
13.49 | 16.12 | 32.58 | 63.70 | 63.39 | 48.75 | (28.15) | (104.32) | (78.11) |
Columns are period end dates · fundamentals updated 25 Oct 2026